Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N C Andrews

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Hematology (Amsterdam, Netherlands)|July 14, 2016
Iron Deficiency Anemia Associated with an Error of Iron Metabolism in Two Siblings: A Thirty Year Follow UpS K Parsons, M D Fleming, D G Nathan, et al.
Blood|September 1, 1992
Enhanced expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor receptor subunits in murine hematopoietic cells stimulated with hematopoietic growth factorsE Liboi, P Jubinsky, N C Andrews, et al.
Nature|April 22, 1993
Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper proteinN C Andrews, H Erdjument-Bromage, M B Davidson, et al.
Cancer|April 1, 1975
Yoshi 864 (NSC 102627) 1-propanol, 3, 3'-iminodi-dimethanesulfonate (ester) hydrochloride: a phase 1 studyS J Altman, W S Fletcher, N C Andrews, et al.
Genes & Development|March 29, 2001
A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) miceM D Fleming, D R Campagna, J N Haslett, et al.
Blood|July 27, 2000
The molecular defect in hypotransferrinemic miceC C Trenor, D R Campagna, V M Sellers, et al.
Blood|September 10, 1998
The G185R mutation disrupts function of the iron transporter Nramp2M A Su, C C Trenor, J C Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Positive and negative elements regulate human interleukin 3 expressionB Mathey-Prevot, N C Andrews, H S Murphy, et al.
Blood|June 25, 1999
The C282Y mutation causing hereditary hemochromatosis does not produce a null alleleJ E Levy, L K Montross, D E Cohen, et al.
Cancer Chemotherapy Reports|February 1, 1971
Phase I study of dibromodulcitol (NSC-104800)N C Andrews, A J Weiss, F J Ansfield, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Hematology (Amsterdam, Netherlands)|July 14, 2016
Iron Deficiency Anemia Associated with an Error of Iron Metabolism in Two Siblings: A Thirty Year Follow UpS K Parsons, M D Fleming, D G Nathan, et al.
Blood|September 1, 1992
Enhanced expression of interleukin-3 and granulocyte-macrophage colony-stimulating factor receptor subunits in murine hematopoietic cells stimulated with hematopoietic growth factorsE Liboi, P Jubinsky, N C Andrews, et al.
Nature|April 22, 1993
Erythroid transcription factor NF-E2 is a haematopoietic-specific basic-leucine zipper proteinN C Andrews, H Erdjument-Bromage, M B Davidson, et al.
Cancer|April 1, 1975
Yoshi 864 (NSC 102627) 1-propanol, 3, 3'-iminodi-dimethanesulfonate (ester) hydrochloride: a phase 1 studyS J Altman, W S Fletcher, N C Andrews, et al.
Genes & Development|March 29, 2001
A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f/f) miceM D Fleming, D R Campagna, J N Haslett, et al.
Blood|July 27, 2000
The molecular defect in hypotransferrinemic miceC C Trenor, D R Campagna, V M Sellers, et al.
Blood|September 10, 1998
The G185R mutation disrupts function of the iron transporter Nramp2M A Su, C C Trenor, J C Fleming, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1990
Positive and negative elements regulate human interleukin 3 expressionB Mathey-Prevot, N C Andrews, H S Murphy, et al.
Blood|June 25, 1999
The C282Y mutation causing hereditary hemochromatosis does not produce a null alleleJ E Levy, L K Montross, D E Cohen, et al.
Cancer Chemotherapy Reports|February 1, 1971
Phase I study of dibromodulcitol (NSC-104800)N C Andrews, A J Weiss, F J Ansfield, et al.
Pageof 7